Shares Outstanding for IDEXX Laboratories (IDXX)
According to IDEXX Laboratories's latest reported financial statements, the company's latest reported diluted shares outstanding is 80.67M. Diluted weighted-average shares outstanding is the share count used to compute per-share metrics like EPS. Buybacks lower it; new issuance, stock-based compensation, and convertible securities raise it. Multiply by the stock price for market capitalization.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
Currently viewingShares OutstandingSwitch metric
Latest period
80.67M
YoY change
-3.1%
5Y CAGR
-1.4%
Peak year (1999)
159.02M
Latest annual
80.67M
Shares Outstanding history chart for IDEXX Laboratories (IDXX) from 1991 to 2025
Shares Outstanding history table for IDEXX Laboratories (IDXX) from 1991 to 2025
| Fiscal year | Period ended | Reported | Shares Outstanding | YoY |
|---|---|---|---|---|
| 2025 | 80.67M | -3.1% | ||
| 2024 | 83.25M | -0.9% | ||
| 2023 | 83.98M | -0.7% | ||
| 2022 | 84.60M | -2.3% | ||
| 2021 | 86.57M | -0.2% | ||
| 2020 | 86.72M | -0.9% | ||
| 2019 | 87.54M | -1.0% | ||
| 2018 | 88.47M | -1.2% | ||
| 2017 | 89.57M | -1.4% | ||
| 2016 | 90.88M | -3.0% | ||
| 2015 | 93.65M | -7.7% | ||
| 2014 | 101.50M | -6.0% | ||
| 2013 | 107.97M | -3.9% | ||
| 2012 | 112.31M | -3.5% | ||
| 2011 | 116.43M | -2.3% | ||
| 2010 | 119.12M | -1.9% | ||
| 2009 | 121.36M | -2.5% | ||
| 2008 | 124.50M | -3.4% | ||
| 2007 | 128.91M | -2.2% | ||
| 2006 | 131.81M | -3.2% | ||
| 2005 | 136.22M | -4.9% | ||
| 2004 | 143.20M | -0.4% | ||
| 2003 | 143.72M | +2.5% | ||
| 2002 | 140.17M | +1.2% | ||
| 2001 | 138.56M | -4.0% | ||
| 2000 | 144.32M | -9.2% | ||
| 1999 | 159.02M | +4.6% | ||
| 1998 | 152.00M | +0.9% | ||
| 1997 | 150.71M | -4.1% | ||
| 1996 | 157.11M | +11.4% | ||
| 1995 | 140.98M | +6.0% | ||
| 1994 | 133.00M | -0.6% | ||
| 1993 | 133.79M | +25.4% | ||
| 1992 | 106.67M | +33.3% | ||
| 1991 | 80.00M | — |
Shares Outstanding values are taken from IDEXX Laboratories's reported income statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
2025's annual diluted shares outstanding for IDEXX Laboratories (IDXX) came in at 80.67M – edged down 3.1% year-over-year.
Through 2020–2025 (5 years), IDEXX Laboratories diluted shares outstanding delivered a -1.4% annualised rate; with a net decline across the window.
IDEXX Laboratories diluted shares outstanding peaked at 159.02M in 1999; the latest annual figure is 80.67M in 2025 (49.3% below peak).
Across the available history, diluted shares outstanding reached its high of 159.02M in 1999 and its low of 80.00M in 1991.
Among 8 Healthcare peers, IDEXX Laboratories (IDXX) ranks 9th; the peer median for diluted shares outstanding is 1.34B.
IDEXX Laboratories Shares Outstanding by Year
IDEXX Laboratories Shares Outstanding 2025: 80.67M
IDEXX Laboratories diluted shares outstanding in 2025 was 80.67M, edged down 3.1% below 2024.
IDEXX Laboratories Shares Outstanding 2024: 83.25M
IDEXX Laboratories diluted shares outstanding in 2024 was 83.25M, edged down 0.9% below 2023.
IDEXX Laboratories Shares Outstanding 2023: 83.98M
IDEXX Laboratories diluted shares outstanding in 2023 was 83.98M, edged down 0.7% below 2022.
IDEXX Laboratories Shares Outstanding 2022: 84.60M
IDEXX Laboratories diluted shares outstanding in 2022 was 84.60M, edged down 2.3% below 2021.
IDEXX Laboratories Shares Outstanding 2021: 86.57M
IDEXX Laboratories diluted shares outstanding in 2021 was 86.57M.
See more financial history for IDEXX Laboratories (IDXX).
Sector peers — Shares Outstanding
Companies in the same sector as IDEXX Laboratories, ranked by their latest diluted shares outstanding.
| Company | Shares Outstanding | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | 4.45B | Healthcare |
| Merck & Co., Inc. (MRK) | 2.51B | Healthcare |
| Johnson & Johnson (JNJ) | 2.43B | Healthcare |
| AbbVie Inc. (ABBV) | 1.77B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | 910.00M | Healthcare |
| Eli Lilly and Company (LLY) | 898.00M | Healthcare |
| AstraZeneca PLC (AZN) | 781.00M | Healthcare |
| Amgen Inc. (AMGN) | 542.00M | Healthcare |
Frequently asked questions
What is IDEXX Laboratories's diluted shares outstanding?
- Latest reported diluted shares outstanding for IDEXX Laboratories (IDXX) is 80.67M (period ending December 31, 2025).
How has IDEXX Laboratories diluted shares outstanding changed year-over-year?
- IDEXX Laboratories (IDXX) diluted shares outstanding changed -3.1% year-over-year on the latest annual filing.
What is the long-term growth rate of IDEXX Laboratories diluted shares outstanding?
- IDEXX Laboratories (IDXX) diluted shares outstanding compound annual growth rate is -1.4% over the most recent 5 years available.
When did IDEXX Laboratories diluted shares outstanding hit its highest annual value?
- IDEXX Laboratories diluted shares outstanding reached its highest annual value of 159.02M in 1999.
What was IDEXX Laboratories diluted shares outstanding in 2024?
- IDEXX Laboratories (IDXX) diluted shares outstanding in 2024 was 83.25M.
What was IDEXX Laboratories diluted shares outstanding in 2025?
- IDEXX Laboratories (IDXX) diluted shares outstanding in 2025 was 80.67M.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
IDXX Overview
Company profile, financial tools, and key metrics
IDXX Revenue Counter
Earns $136.47 every second. See per minute, hour, and day.
IDXX Earnings Counter
Earns $33.60 per second net profit. See per minute, hour, and day.
IDXX Economic Scale
Exceeds Aruba's GDP. Compare with world economies.
IDXX What If Invested
What if you had invested $1,000? See historical returns from any date.
IDXX How It Makes Money
Discover visual breakdown of $4.30B in revenue — where it comes from and where it goes.
IDXX Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
IDXX Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
IDXX Daily Price Character
Explosive · 50.9% historical win rate (green days). Streaks & record days.
IDXX Buybacks
2.25% TTM buyback yield. Shareholder yield & SBC comparison.
IDXX Stock Split History
4 splits on record. Dates, ratios, and cumulative multiple.